217 related articles for article (PubMed ID: 25856433)
21. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP
Qi H; Shen D; Jiang C; Wang H; Chang M
Neurosci Lett; 2021 Jan; 741():135493. PubMed ID: 33181233
[TBL] [Abstract][Full Text] [Related]
22. Redox activated MAP kinase death signaling cascade initiated by ASK1 is not activated in female mice following MPTP: novel mechanism of neuroprotection.
Saeed U; Karunakaran S; Meka DP; Koumar RC; Ramakrishnan S; Joshi SD; Nidadavolu P; Ravindranath V
Neurotox Res; 2009 Aug; 16(2):116-26. PubMed ID: 19526288
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
24. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotection of Sevoflurane Against Ischemia/Reperfusion-Induced Brain Injury Through Inhibiting JNK3/Caspase-3 by Enhancing Akt Signaling Pathway.
Wen XR; Fu YY; Liu HZ; Wu J; Shao XP; Zhang XB; Tang M; Shi Y; Ma K; Zhang F; Wang YW; Tang H; Han D; Zhang P; Wang SL; Xu Z; Song YJ
Mol Neurobiol; 2016 Apr; 53(3):1661-1671. PubMed ID: 25687432
[TBL] [Abstract][Full Text] [Related]
26. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.
Li X; MacLeod R; Dunlop AJ; Edwards HV; Advant N; Gibson LC; Devine NM; Brown KM; Adams DR; Houslay MD; Baillie GS
FEBS Lett; 2009 Oct; 583(20):3310-6. PubMed ID: 19782076
[TBL] [Abstract][Full Text] [Related]
27. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
28. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
Perry-Hauser NA; Kaoud TS; Stoy H; Zhan X; Chen Q; Dalby KN; Iverson TM; Gurevich VV; Gurevich EV
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955810
[TBL] [Abstract][Full Text] [Related]
29. Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.
Qiao C; Zhang LX; Sun XY; Ding JH; Lu M; Hu G
Mol Neurobiol; 2017 Aug; 54(6):4292-4302. PubMed ID: 27339879
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin.
Gao HL; Li C; Nabeka H; Shimokawa T; Saito S; Wang ZY; Cao YM; Matsuda S
Neuroscience; 2013 Apr; 236():373-93. PubMed ID: 23321539
[TBL] [Abstract][Full Text] [Related]
31. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
32. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
[TBL] [Abstract][Full Text] [Related]
34. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.
Filichia E; Hoffer B; Qi X; Luo Y
Sci Rep; 2016 Sep; 6():32656. PubMed ID: 27619562
[TBL] [Abstract][Full Text] [Related]
36. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
Bao XQ; Kong XC; Qian C; Zhang D
Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
[TBL] [Abstract][Full Text] [Related]
37. RIPK1 inhibitor ameliorates the MPP
Liu J; Hu H; Wu B
Brain Res; 2021 Apr; 1757():147310. PubMed ID: 33524379
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
Zhang L; Huang L; Chen L; Hao D; Chen J
Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
[TBL] [Abstract][Full Text] [Related]
40. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]